Rescue inhaler

Abstract

A portable rescue inhaler having a first canister containing a gas mixture of helium, oxygen, and nitrogen, and having a second canister containing an aerosolized medicine. The gas mixture of helium, oxygen, and nitrogen contained in the first canister has a density slightly lower than the density of atmospheric air. The portable rescue inhaler is capable of delivering the lower density gas mixture simultaneously with the aerosolized medicine for emergency hand held rescue of patients suffering from asthma, asthmatic bronchitis, COPD, emphysema, cystic fibrosis, and myocardial insufficiency. The portable rescue inhaler is capable of providing a vaporized anesthetic for greater medical assistance for patients in need of anesthesia due to respiratory insufficiency. The portable rescue inhaler reduces intra-operative risks in respiratory patients prior to gaining access to a hospital or care center.

Claims

1. A rescue inhaler comprising: a body having first and second connector portals; a first canister attachable to the first connector portal storing a gas mixture comprising helium, oxygen, nitrogen, and air gases; wherein the gas mixture has a density that is lower than the density of atmospheric air; a second canister attachable to the second connector portal storing an aerosolized medicine; wherein the aerosolized medicine stored in the second canister is sprayed into an aerosol path when the second canister attached to the second connector portal is threaded past a threshold; and a push button located outside the body of the rescue inhaler for activating a valve for releasing the gas mixture of the first canister into a gas path; wherein the gas mixture flowing in the gas path pulls the aerosolized medicine from the aerosol path into the gas path leading the aerosolized medicine and the gas mixture to be discharged out of a month outlet; wherein the first and second canisters have threaded necks allowing the first and second canisters to be screwed onto corresponding threads of the first and second connector portals, respectively.

2. The rescue inhaler of claim 1, further comprising: a flap valve within the gas path for preventing back flow when the rescue inhaler is not in use or during exhalation from a user into the rescue inhaler via the mouth outlet.

3. The rescue inhaler of claim 1, wherein different first canisters containing different concentrations of helium, oxygen, and nitrogen gas can be interchangeably attached to the first connector portal.

4. The rescue inhaler of claim 1, wherein different second canisters containing different aerosolized medicines can be interchangeably attached to the second connector portal.

5. The rescue inhaler of claim 1, wherein the aerosolized medicine stored in the second container is an airway opening drug, called a bronchodilator.

6. The rescue inhaler of claim 1, wherein the aerosolized medicine stored in the second container is an antibiotic medication.

7. The rescue inhaler of claim 1, wherein the valve for releasing the gas mixture of the first canister is a Schrader valve.

8. The rescue inhaler of claim 7, wherein the push button activates the Schrader valve by unseating the Schrader valve under spring pressure.

9. The rescue inhaler of claim 1, wherein the first canister is made of a metal material and the second canister is made of a plastic or metal material.

10. The rescue inhaler of claim 1, wherein the gas mixture released from the first canister carries the aerosol drug released from the second canister into a user's lungs.

11. The rescue inhaler of claim 1, wherein only the gas mixture from the first canister is released without having the aerosolized medicine released by the second canister.

12. The rescue inhaler of claim 1, wherein only the aerosolized medicine from second canister is released without having the gas mixture of the first canister released.

13. The rescue inhaler of claim 1, wherein the gas mixture comprises helium having a concentration not greater than 55%, and oxygen having a concentration not greater than 40% for reducing the density of the gas mixture below the density of atmospheric air to achieve laminar flow in most distal communicating airways.

14. The rescue inhaler of claim 1, wherein the mixture of gas flowing in the gas path passes a restricted orifice creating suction in a capillary tube in the aerosol path, sucking-up the aerosolized medicine in the capillary tube, leading the aerosolized medicine to flow with the gas mixture in the gas path, and leading the aerosolized medicine and the gas mixture to be discharged out of the mouth outlet.

15. The room inhaler of claim 1, wherein the rescue inhaler body is breakable into two halves, thereby physically separating a first half carrying the first canister from a second half carrying the second canister.

16. The rescue inhaler of claim 1, wherein the first and second connector portals are places on a first portion of the body, and wherein the body further comprises a grip handle on a second portion of the body, which is direct opposite to the first portion.

17. A rescue inhaler comprising: a body having first and second connector portals; a first canister attachable to the first connector portal storing a gas mixture comprising helium, oxygen, nitrogen, and air gases; wherein the gas mixture has a density that is lower than the density of atmospheric air; a second canister attachable to the second connector portal storing an aerosolized medicine; wherein the aerosolized medicine stored in the second canister is sprayed into an aerosol path when the second canister attached to the second connector portal is pushed upwards; a push button located outside the body of the rescue inhaler for activating a valve for releasing the gas mixture of first canister into a gas path; wherein the gas mixture flowing in the gas path pulls the aerosolized medicine from the aerosol path into the gas path leading the aerosolized medicine and the gas mixture to be discharged out of a mouth outlet; and an attachable anesthetic adapter that fits over the mouth outlet; wherein the anesthetic adapter comprises an interior sliding ring haying attached pockets; wherein a wax or non-toxic sugar coated envelope is placed into each pocket on the sliding ring; wherein each envelope has an anesthetic in liquid or semi-solid state form; wherein a heater powered by a small insertable ion battery melts the envelope and vaporizes the anesthetic for inhalation.

18. The rescue inhaler of claim 17, wherein the vaporized anesthetic is inhaled with or without the aerosolized medicine from the second canister.

19. The rescue inhaler of claim 18, wherein the vaporized anesthetic is inhaled with or without the gas mixture from the first canister.

20. A rescue inhaler comprising; a body having first and second connector portals; a first canister attachable to the first connector portal storing a gas mixture comprising helium, oxygen, nitrogen, and air gases; wherein the gas mixture has a density that is lower than the density of atmospheric air; a second canister attachable to the second connector portal storing an aerosolized medicine; and wherein the aerosolized medicine stored in the second canister is sprayed into an aerosol path when the second canister attached to the second connector portal is threaded past a threshold; a push button located outside the body of the rescue inhaler for activating a valve for releasing the gas mixture of the first canister into a gas path; wherein the gas mixture flowing in the gas path pulls the aerosolized medicine from the aerosol path into the gas path leading the aerosolized medicine and the gas mixture to be discharged out of a mouth outlet; wherein screwing the second canister past a line on the second connector portal opens a secondary valve on the second canister for continuously discharging the aerosolized medicine from the second canister.

Description

DESCRIPTION OF THE FIGURES

(1) FIG. 1 shows a side view of an embodiment of the rescue inhaler of the present invention.

(2) FIG. 2 shows a cut-through view of the internal components of an embodiment of the rescue inhaler of the present invention.

(3) FIG. 3 shows a view of the gas and aerosol/medicine path in an embodiment of the rescue inhaler of the present invention.

(4) FIG. 4A shows a view of a Schrader type valve used in an embodiment of the rescue inhaler of the present invention in which the valve is unseated by a block of composite material, and FIG. 4B shows a view of a Schrader type valve used in an embodiment of the rescue inhaler of the present invention in which the valve is seated.

(5) FIG. 5 shows a view of the gas and aerosol/medicine path in an embodiment of the rescue inhaler of the present invention.

(6) FIG. 5a shows a view of a secondary valve on the second canister in an embodiment of the rescue inhaler of the present invention.

(7) FIG. 6 shows an anesthetic attachment used in an embodiment of the rescue inhaler of the present invention.

(8) FIG. 7 shows a view of a Schrader type valve, (a) front seated, (b) back seated, and (c) mid-positioned, as used in an embodiment of the rescue inhaler of the present invention.

(9) The invention will next be described in connection with certain exemplary embodiments; however, it should be clear to those skilled in the art that various modifications, additions, and subtractions can be made without departing from the spirit or scope of the claims.

DETAILED DESCRIPTION OF THE INVENTION

(10) FIGS. 1 and 2 show an embodiment of the rescue inhaler with two attached canisters (1, 2). The first canister (1) is made of a metal material and the second canister (2) is made of a plastic or light metal material. The two canisters are screwed into the bottom of the rescue inhaler. The two canisters (1, 2) have threaded necks (8) for screwing them onto connector portals having corresponding threads (9).

(11) The first canister (1) is a pressurized gas container having a mixture of at least three different gases including helium, oxygen, and nitrogen. The mixture of helium, oxygen, and nitrogen contained in the first canister (1) is designed for having a density that is slightly lower than the density of atmospheric air. By having a lower density than atmospheric air, the mixture of helium, oxygen, and nitrogen increases a patient's ease of breathing while simultaneously providing greater gas and aerosol deposition within the tracheobronchial tree of the patient and decreasing the ventilation to perfusion mismatching commonly experienced by COPD patients.

(12) Different first canisters (1) containing different concentrations of helium, oxygen, and nitrogen can be interchangeably used with the rescue inhaler. As shown in FIG. 2, a first canister (1) having threads (8) can be screwed and unscrewed from the bottom of the rescue inhaler body (4) having threads (9). Thus, the rescue inhaler can be optimized to fit the particular needs of a particular patient/user by attaching a first canister (1) that has optimal concentrations of helium, oxygen, and nitrogen. Examples of gas mixtures that can be supplied by the first canister (1), each containing different concentrations of helium, oxygen, and nitrogen, are described below:

(13) Example 1. % of He is 28% (0.2800.178)+% of O.sub.2 is 23% (0.2301.43)+% of N.sub.2 is 30% (0.3001.25)+19% air (0.191.29 g/l)

(14) He=0.049+O.sub.2=0.3289+N.sub.2=0.375+Air=0.245=d avg.=0.9979 g/l
Example 2. % of He is 30% (0.3000.178)+% of O.sub.2 is 25% (0.2501.43)+% of N.sub.2 is 30% (0.3001.25)+15% air (0.151.29)=d avg. He=0.053+0.3575+0.375+0.193=d avg.=0.9875 g/l
Example 3. % of He is 30% (0.300.178)+% of O.sub.2 is 40% (0.401.43)+% of N.sub.2 is 25% (0.251.25)+5% air (0.051.29)=d avg. He=0.0534+O.sub.2=0.572+N.sub.2=0.3125+Air=0.0645=d avg.=1.108 g/l
Example 4. % of He is 20% (0.020.178)+% of O.sub.2 is 30% (0.301.43)+% of N.sub.2 is 40% (0.401.25)+10% air (0.101.29)=d avg. He=0.0356+O.sub.2=0.429+N.sub.2=0.5+air=0.129=d avg.=1.0936 g/l
Example 5. % He is 35% (0.3500.178)+% O.sub.2 is 35% (0.3501.43)+% of N.sub.2 is 20% (0.201.25)+10% air (0.101.29)=d avg. He=0.062+O.sub.2=0.501+N.sub.2=0.25+air=0.129=d avg.=0.942 g/l
Example 6. % He is 55% (0.550.178)+% O.sub.2 is 25% (0.251.43)+% N.sub.2 is 10% (0.101.25)+10% air (0.1001.29)=d avg. He=0.098+O.sub.2=0.357+N.sub.2=0.125+air=0.129=d avg.=0.709 g/l

(15) In addition to these six examples, it is contemplated that additional mixtures of helium, oxygen and nitrogen having a lower density than atmospheric air are possible. Therefore, the rescue inhaler of the present invention is not limited to having canisters containing the six above examples of helium, oxygen and nitrogen concentrations.

(16) The second canister (2) contains an aerosolized medicine that can be either an airway opening drug, called a bronchodilator, or an antibiotic medication. The second canister (2) may be comprised of a disposable plastic low weight container from which the aerosol medicine is pulled. Different aerosolized medicines may be utilized simply by switching the second canister (2) with another canister. For example, a second canister (2) having an unwanted aerosolized medicine can be unscrewed and a new second canister (2) having a desired aerosolized medicine can be screwed in its place.

(17) FIG. 5 shows a capillary tube (6) for pulling the aerosol drug into gas path (10) (see FIGS. 2 and 3) which may contain a flow of the gas mixture released from the first canister (1). FIG. 3 shows an aerosol path (11) combining with the gas path (10) for discharging the mixture of gases released from the first canister (1) and the aerosol drug released from the second canister (2) into the mouth outlet (7) for inhalation by a patient/user of the rescue inhaler. FIG. 3 further shows a small flap valve (13) within the gas path (10) for preventing back flow when the rescue inhaler is not in use or during exhalation by the user into the rescue inhaler via the mouth outlet (7).

(18) FIG. 1 shows a manual push button (3a) for activating the Schrader type valve (3b), shown in FIG. 4, by unseating and seating the valve under spring pressure. This allows the contained gas mixture of the first canister (1) to be released. The gas mixture of the first canister (1) may be used to carry the aerosol drug released by the second canister (2) into the user's lungs. Alternatively, a user of the rescue inhaler may breathe only the gas mixture from the first canister (1) without having the aerosol drug released by the second canister (2). As another alternative, the user of the rescue inhaler may inhale only the aerosol drug released by the second canister (2) without having the gas mixture of the first canister (1) released.

(19) As shown in FIG. 2, the mixture of gases is released into to the gas path (10) of the rescue inhaler. The mixture of helium, oxygen, and nitrogen are released from the first canister (1) by manual activation by pressing a push button (3a) such as the Schrader type valve (3b) shown in FIG. 4. By pressing the push button (3a), a valve compressing spring (14) is unseated. As shown in FIG. 5, this releases the gas mixture of helium, oxygen, and nitrogen into gas path (10) and this gas mixture is later combined with the aerosol drug exiting capillary tube (6) from the second canister (2). The gas mixture of helium, oxygen, and nitrogen combined with the aerosol drug is then discharged to the mouth outlet (7) of the rescue inhaler for inhalation by a patient/user.

(20) FIGS. 1 and 2 show a grip handle (5) for a patient/user to slide their hand around for griping the rescue inhaler. FIG. 2 shows a cut through section (12) allowing a patient/user to grip the rescue inhaler in an even more secure manner. The cut through section (12) together with the handle (5) enables secure handling of the rescue inhaler.

(21) FIG. 3 shows the first canister (1) which is a pressurized gas mixture of helium, oxygen, and nitrogen. As already described, it is contemplated that different canisters having different concentrations of helium, oxygen, and nitrogen can be interchangeably used with the rescue inhaler by screwing and unscrewing the different canisters onto the bottom of the rescue inhaler body (4). The gas mixture of helium, oxygen, and nitrogen released by the first canister (1) is designed to have a density that is slightly lower than the density of atmospheric air for improving a patient's ease of breath. However, care is taken to ensure that the density of helium, oxygen, and nitrogen is not too low so that velocity of the gas mixture entering the lungs of the patient is too fast causing an alveoli washout leading to further ventilation perfusion mismatching and consequently causing further respiratory distress.

(22) FIG. 5 shows that by pressing the push button (3a), shown in FIG. 1, for activating the Schrader type valve (3b), shown in FIG. 4, the pressurized gas mixture from the first canister (1) flows though gas path (10), passes the hinged flap valve (13), shown in FIGS. 2 and 3, and then passes through a restricted orifice (27) to pull via suction liquid medicine up capillary tube (6) into a post restriction enlargement area (28) for discharging into mouth outlet (7) the combined gas mixture and medicine.

(23) FIG. 3 shows the gas path (10) taken by the pressurized gases contained within the first canister (1) being a mixture of varying concentrations of helium, oxygen and nitrogen. The mixture of helium, oxygen, and nitrogen are designed to have particular concentrations to combat the pathophysiology of the patient/user and to have specific properties to maintain a near normal gas air density.

(24) FIG. 4 shows an example of the Schrader type valve (3b) for use with the present invention. At position A, the valve seat is off the block of composite material allowing gas path (10) to freely move across the aerosol path (11) shown in FIG. 2.

(25) In one embodiment of the invention, both the first and second canisters (1, 2) have a Schrader valve (3b) for controlling the release of their pressurized contents. In this embodiment, the Schrader valve (3b) for the second canister (2) is just above the aerosol path (11).

(26) FIG. 5 provides a closer view of the gas path (10) which shows it flowing past a restricted orifice (27) and past a post restriction enlargement area (28) creating suction in capillary tube (6) and causing aerosol medicine to be suctioned up capillary tube (6). The aerosol medicine then flows along with the gas path (10) so that it is discharged out of the mouth outlet (7). This allows both the aerosol medicine and the mixture of helium, oxygen, and nitrogen to be inhaled by the patient/user.

(27) The lower density and elevated oxygen concentration of the gas mixture from the first canister (1) combined with the aerosol medicine released by the second canister (2) allows greater aerosol medicine penetration depth into the lungs of users who suffer from COPD and also increases ventilation thereby improving oxygenation and carbon dioxide elimination in the user of the rescue inhaler. Moreover, this simultaneously decreases the work of breathing by the user and improves the dissemination of the gases and aerosol medicine deposition within the damaged COPD lung fields of the user.

(28) By keeping the density of the gas mixture contained in the first canister (1) slightly below that of normal air, this slows down the velocity of the inhaled gases allowing for laminar flow in the most distal smallest communicating airways of the lungs of the user. This has the benefit of optimizing V/Q ratios over that of the prior art.

(29) As seen by the present inventor, inhalation by emphysematous lungs of high concentrations of helium gas, above 60-65%, and high concentrations of oxygen, above 55%, creates alveolar gas washouts causing the closure of moderately and more distal lung fields and even slightly damaged air sacs (i.e., alveoli). Two factors are responsible for the worsening of V/Q ratios leading to greater and more frequent respiratory failures. The first factor is high helium gas concentrations which cause an increased gas flow velocity approaching, and in smaller airway regions, exceeding the Reynolds number which causes turbulence and ineffective ventilation. The second factor is air sac filler gases (e.g., nitrogen). For example, air comprises 20.94% oxygen which keeps the alveoli open, inflated, and intercommunicating alveoli pores of khan full by maintaining a proper density by virtue of both the gas density inhaled and the atmospheric pressure.

(30) Referring to FIG. 4, no gas can flow past the valve (3b) when the valve (3b) is seated. The gas path (10) shown in FIG. 3 is still a path, but there is no flow of the gas mixture from the first container (1) until the spring (14) is manually compressed for unseating valve (3b). The second canister (2) may be manually compressed to activate the spray of the aerosol medicine as done in previously known metered-dosage inhalers. One compression of the second canister (2) produces one spay of typically 80 to 95 micrograms of aerosol medicine ejected into the aerosol path (11) and out into the common gas path for inhalation by the patient/user via the mouth outlet (7).

(31) Alternatively, when the lower density gas mixture of helium, oxygen, and nitrogen from the first canister (1) flows through the gas path (10) and aspirates, the aerosol medicine is suctioned up capillary tube (6) slightly past restricted orifice (27) in an ongoing fashion until unneeded or the supply is exhausted. If either the supply of the pressurized gas mixture of the first canister (1) or the aerosolized medicine of the second canister (2) are exhausted, each canister can be replaced by another appropriate canister by unscrewing the exhausted canister and replacing it with a new canister which can be screwed onto the rescue inhaler body (4).

(32) In an embodiment of the present invention, FIG. 6 shows an attachable anesthetic adapter (23) that can be connected to and disconnected from the rescue inhaler. The anesthetic adapter (23) fits over the mouthpiece of the rescue inhaler and is connected to the mouthpiece outlet (7) by a push-fit or is screwed into place. The anesthetic adapter (23) has its outer circumference (19) being a fixed outer surface slightly larger than the mouth outlet (7) so that it may be easily push-fitted or screwed onto the mouth outlet (7).

(33) The anesthetic adapter (23) has an interior sliding ring (18) having attached pockets (20). A wax and or non-toxic sugar coated envelope (21) is dropped or placed into each pocket (20) on the sliding ring (18). Within each envelope (21) is an anesthetic in liquid/semi-solid state in a fixed amount. The liquid/semi-solid anesthetic may be readily vaporized by a heater (22) powered by a small insertable ion battery (17) for vaporizing an envelope (21) and freeing its contents for inhalation by the user at exit (15). The patient/user may inhale the vaporized anesthetic with or without any aerosol medicine from the second canister (2). Similarly, the patient/user may inhale the vaporized anesthetic with or without the low density gas mixture of helium, oxygen, and nitrogen from the first canister (1).

(34) A pocket (20) on the sliding ring (18) matches up with an opening that has a small receptacle (16) below it allowing an envelope (21) held by pocket (20) to be dropped into the receptacle (16). The receptacle (16) is connected to a battery that heats up the sides and bottom of the receptacle (16) so that the envelope (21) containing the liquid and/or semi-solid anesthetic held by the receptacle (16) is also heated. The receptacle (16) is made of ceramic or other heat resistant material. The anesthetic contained in the wax and or non-toxic sugar coated envelope (21) is a fraction of the MAC that would cause laryngospasm and or loss of consciousness.

(35) To receive treatment from the rescue inhaler, a patient/user having difficulty breathing either due to an asthmatic and/or emphysematous condition would take out the rescue inhaler, press the push button (3a) to release the Schrader type relief valve (3b), compress the second canister (2) containing aerosolized medicine, and inhale. The aerosolized medicine from the second canister (2) may be powered by the mixture of helium, oxygen, and nitrogen from the first canister (1) for providing increased medicine deposition farther into the diseased and problematic airways of the user, easing the user's work of breathing, and for providing supplemental oxygen. In view of these benefits, the rescue inhaler of the present invention allows for increased emergency rescue.

(36) The second canister (2) is powered by gas driven either from the first canister (1) or by self-contained pressure whereby a user pushes the second canister (2) upwards to eject one spray, typically 80 to 90 micrograms of aerosolized medicine.

(37) Alternatively, if the second canister (2) is threaded past a red line (26) by screwing the external threads (8) of the second canister (2) past a threshold in the threads (9) of the rescue inhaler body (4), a cover of a secondary valve (25) shown in FIG. 5a is slid off keeping the secondary valve (25) opened into the gas path (10) generating suction via the restricted orifice (27) for sucking up the aerosolized medicine via capillary tube (6) and for continuously discharging the aerosolized medicine from the second canister (2) to the patient/user. Thus, if a patient has a severe asthma attack, the second canister (2) can be screwed past the red line (26), meaning all the way up the internal threads (9) of the rescue inhaler body (4), so that the aerosol medicine contained in the second canister (2) flows continuously up the aerosol path (11) and continuously flows into the gas path (10) for continuously discharging the aerosolized medicine to the patient/user.

(38) Keeping the secondary valve (25) opened in the compressed condition allows for the ongoing spray of the aerosolized medicine from the second canister (2). The ongoing spray of aerosolized medicine is then powered to the mouth outlet (7) by the mixture of helium, oxygen, and nitrogen gas. The mixture of helium, oxygen, and nitrogen gas is emitted from the first canister (1) by pressing and holding the push button (3a) on the external body (4) of the rescue inhaler which compresses the valve spring (14) thereby activating the Schrader type valve (3b) by allowing the valve seat A to be unseated.

(39) The push button (3a) acts as a safety mechanism by preventing inadvertent activation of the Schrader type valve (3b). The push button (3a) also provides a user with the ability to either continually keep the push button (3a) depressed, or to alternatively pause and press the push button (3a) over time for conserving the helium, oxygen, and nitrogen mixture. This also allows the user to judge the effects of the helium, oxygen, and nitrogen mixture combined with the aerosolized medicine over time, thus truly allowing patient/user full control over their treatment.

(40) The second canister (2) must be screwed onto the threads (9) of the rescue inhaler body past a red line (26) that is marked on the outside of the body (4) of the rescue inhaler so that the red line (26) is visible to a user. This causes the sliding of a valve cover of a secondary opening (25) within the container neck of the second canister (2). This is shown in FIG. 5a. The cover of said valve when removed allows for contents of the second canister (2) to be sucked up into the gas path (10) of the rescue inhaler.

(41) In view of the above, a user may use the present rescue inhaler invention intermittently, for example, to take a spray of the aerosolized medicine from the second canister (2) by depressing the second canister (2) one time as done with previously known metered-dosage inhalers. Alternatively, the user may use the first canister (1) for emitting a mixture of helium, oxygen, and nitrogen that is specifically designed to have a density that is slightly lower than the density of atmospheric air for breathing either alone or along with the aerosolized medicine sprayed from the second canister (2).

(42) A user may use a continuous spray of the aerosolized medicine from the second canister (2) powered by the helium, oxygen, nitrogen gas mixture from the first canister (1) for a prolonged period (e.g., forty seconds or a minute and a half). The user may then stop the treatment to gage its effect over time. Such treatment not only eases the work of breathing for the user and supplies supplemental oxygen to the user, but also generates greater penetrating depth for the aerosolized medicine in the user's airways. The aerosolized medicine from the second canister (2) reaches farther down into the user's airways due to the mixture of gases (helium, oxygen, nitrogen) from the first canister (1) having a density that is slightly lower than the density of atmospheric air.

(43) Additional embodiments and variations of the above described rescue inhaler invention are contemplated. For example, although the embodiments described above have two pressurized canisters (one containing a mixture of helium, oxygen, and nitrogen, the other containing aerosolized medicine), it is contemplated that there may be other embodiments having only one canister. In one particular embodiment, a rescue inhaler with only a single canister comprising a mixture of oxygen and helium gas along with an anesthetic ability added to the gas mixtures is contemplated.

(44) Moreover, it is envisioned that different canisters having different concentrations of oxygen may be used with the present invention. Although, such concentrations of oxygen are not to exceed 35%, it is contemplated that higher oxygen percentages when deemed sound and clinically necessary may be used. It is further contemplated that different canisters with different concentrations of helium may be used with the present invention. Such concentrations of helium are generally not to exceed 50%.

(45) An additional aspect of the present invention is an anesthetic adapter (23) acting as a cap that fits over or push fits onto the exiting mouthpiece section (7) of the present rescue inhaler invention. The anesthetic adapter (23) has pockets or grooves (20) that are set in a rotating collar or sliding ring (18) such that the rotating collar or sliding ring (18) allows for the dispensing of meltable envelopes (21) contained within the pockets or grooves (20) when put into a position that is heated by a heating source (22) powered by a battery (17) as shown in FIG. 6. The meltable envelopes (21) have an anesthesia liquid and/or semi-solid form of anesthesia agent for both relaxation and increased bronchodilation. Moreover, the anesthesia agent in the meltable envelopes (21) also combats inflammation and spasms within the tracheobronchial tree and other vessels of the user.

(46) In another embodiment, the rescue inhaler body (4) splits in half so that if a user desires to use the rescue inhaler as only a metered-dosage inhaler, the user can break the rescue inhaler body (4) into two halves and use only the half corresponding to the second canister (2) containing the aerosolized medicine. For example, if the user does not have a need for the first canister (1), the half pertaining to the first canister (1) having the helium, oxygen, and nitrogen gas mixture can be left at home so that the portable rescue inhaler is even more portable.

(47) Additionally, the rescue inhaler could be sold in separate pieces so that a user, who only has a need for a metered-dosage inhaler, can buy the piece corresponding to the second canister (2) for administering an aerosolized medicine without having to buy the other piece corresponding to the first canister (1) for administering the helium, oxygen, and nitrogen gas mixture. Thus, the portable rescue can be made more economical for individual users based on their needs by selling pieces of the rescue inhaler body (4) separately. Moreover, if the user eventually develops a need for the first canister (1) containing a supply of the helium, oxygen, nitrogen gas mixture, the user can buy the piece corresponding to the first canister (1). Thus, the rescue inhaler is adaptable to a user's needs which may change over time.

(48) While various embodiments of the present invention have been described above, it should be understood that they have been presented by way of example, and not limitation. It will be apparent to persons skilled in the relevant art(s) that various changes in form and detail can be made therein without departing from the spirit and scope of the present invention. Thus, the present invention should not be limited by any of the above-described exemplary embodiments, but should be defined only in accordance with the following claims and their equivalents.

(49) In addition, it should be understood that the illustrated figures, which highlight the functionality and advantages of the present invention, are presented for example purposes only. The architecture of the present invention is sufficiently flexible and configurable, such that it may be utilized in ways other than that shown in the accompanying figures.

(50) Further, the purpose of the foregoing Abstract is to enable the U.S. Patent and Trademark Office and the public generally, and especially the scientists, engineers and practitioners in the art who are not familiar with patent or legal terms or phraseology, to determine quickly from a cursory inspection the nature and essence of the technical disclosure of the application. The Abstract is not intended to be limiting as to the scope of the present invention in any way.